A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
Status:
Not yet recruiting
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and
Safety of RIST4721 in Subjects with Hidradenitis Suppurativa